We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
-20.76%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$494M
AUM Growth
-$1.01B
Cap. Flow
-$858M
Cap. Flow %
-173.65%
Top 10 Hldgs %
68.64%
Holding
144
New
30
Increased
10
Reduced
31
Closed
51

Sector Composition

Rank Sector Weight
1 Healthcare 4.71%
2 Technology 3.8%
3 Communication Services 3.01%
4 Consumer Discretionary 2.95%
5 Energy 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
26
Amazon
AMZN
$2.92T
$3.75M 0.76%
50,000
QQQ icon
27
Invesco QQQ Trust
QQQ
$453B
$3.55M 0.72%
+23,000
New +$3.85M
ZGNX
28
DELISTED
Zogenix, Inc.
ZGNX
$3.16M 0.64%
86,600
-9,000
-9% -$368K
GLNG icon
29
Golar LNG
GLNG
$5B
$3.12M 0.63%
143,400
AGS
30
DELISTED
PlayAGS
AGS
$2.76M 0.56%
120,000
+20,635
+21% +$490K
EVBG
31
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.67M 0.54%
46,950
FXI icon
32
iShares China Large-Cap ETF
FXI
$4.37B
$2.54M 0.51%
+65,000
New +$2.63M
SPY icon
33
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.5M 0.51%
+10,000
New +$2.7M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.57B
$2.24M 0.45%
20,500
JT
35
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$2.15M 0.43%
64,312
NOK icon
36
Nokia
NOK
$51B
$2.04M 0.41%
+350,000
New +$1.96M
RGNX icon
37
Regenxbio
RGNX
$620M
$1.99M 0.4%
47,500
AXGN icon
38
Axogen
AXGN
$2.27B
$1.96M 0.4%
95,669
+693
+0.7% +$21.7K
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.36T
$1.88M 0.38%
36,000
XENE icon
40
Xenon Pharmaceuticals
XENE
$6.06B
$1.6M 0.32%
253,300
-211,000
-45% -$1.88M
ARGX icon
41
argenx
ARGX
$54.6B
$1.56M 0.32%
16,000
-9,000
-36% -$800K
CDNA icon
42
CareDx
CDNA
$2.26B
$1.54M 0.31%
61,160
BBGI icon
43
Beasley Broadcasting Group
BBGI
$37.8M
$1.53M 0.31%
20,426
-2,074
-9% -$234K
SVXY icon
44
ProShares Short VIX Short-Term Futures ETF
SVXY
$228M
$1.48M 0.3%
+70,000
New +$1.72M
CQQQ icon
45
Invesco China Technology ETF
CQQQ
$3.03B
$1.38M 0.28%
+35,000
New +$1.48M
QTNT
46
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.35M 0.27%
+5,500
New +$1.44M
URBN icon
47
Urban Outfitters
URBN
$6.35B
$1.33M 0.27%
+40,000
New +$1.5M
VIAV icon
48
Viavi Solutions
VIAV
$9.12B
$1.14M 0.23%
113,160
+24,760
+28% +$267K
OPNT
49
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$1.08M 0.22%
75,000
NDLS icon
50
Noodles & Co
NDLS
$111M
$943K 0.19%
16,856
-17,519
-51% -$1.3M

Similar funds

Granite Point Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Granite Point Capital Management held 144 positions worth $494M, down 67% from $1.51B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Granite Point Capital Management withdrew a net $858M in Q4 2018, closing 51 positions and reducing 31 holdings. Its most notable exit was Tellurian Inc., an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.7% of assets, up from 3.2% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Granite Point Capital Management opened a new position in ZENDESK INC worth $3.91M.

  • Granite Point Capital Management's largest Q4 2018 buy was ZENDESK INC: 67,000 shares worth $3.91M.
  • Granite Point Capital Management added most to Marinus Pharmaceuticals, Inc in Q4 2018, an estimated $8.09M increase.
  • Granite Point Capital Management's biggest Q4 2018 reduction was Senseonics Holdings Inc, cutting an estimated $2.33M.
  • Granite Point Capital Management fully exited Tellurian Inc. in Q4 2018, selling an estimated $4.87M.
  • Granite Point Capital Management's ten largest holdings make up 69% of its $494M portfolio in Q4 2018.
  • Granite Point Capital Management opened 30 new positions and closed 51 in Q4 2018.
  • Granite Point Capital Management's portfolio value fell 67% quarter-over-quarter to $494M.

Based on Granite Point Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.